319 related articles for article (PubMed ID: 22820603)
1. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.
Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603
[TBL] [Abstract][Full Text] [Related]
2. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.
Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM
Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602
[TBL] [Abstract][Full Text] [Related]
3. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
4. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
5. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
[TBL] [Abstract][Full Text] [Related]
6. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
7. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
8. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
[TBL] [Abstract][Full Text] [Related]
9. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
10. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
[TBL] [Abstract][Full Text] [Related]
11. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
12. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
[TBL] [Abstract][Full Text] [Related]
14. [Sulfatide-loaded CD1d tetramer to detect typeII NKT cells in mice].
Zhang GQ; Nie HX; Yang J; Yu HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):696-8. PubMed ID: 22768857
[TBL] [Abstract][Full Text] [Related]
15. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
[TBL] [Abstract][Full Text] [Related]
17. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex.
Wun KS; Ross F; Patel O; Besra GS; Porcelli SA; Richardson SK; Keshipeddy S; Howell AR; Godfrey DI; Rossjohn J
J Biol Chem; 2012 Nov; 287(46):39139-48. PubMed ID: 22995911
[TBL] [Abstract][Full Text] [Related]
18. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
19. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
20. The yin and yang of CD1d recognition.
Adams EJ; Luoma AM
Nat Immunol; 2012 Sep; 13(9):814-5. PubMed ID: 22910387
[No Abstract] [Full Text] [Related]
[Next] [New Search]